336 related articles for article (PubMed ID: 26193962)
21. Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study.
Loungnarath R; Causeret S; Bossard N; Faheez M; Sayag-Beaujard AC; Brigand C; Gilly F; Glehen O
Dis Colon Rectum; 2005 Jul; 48(7):1372-9. PubMed ID: 15909071
[TBL] [Abstract][Full Text] [Related]
22. Cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy (HIPEC) in the treatment of pseudomyxoma peritonei: ten years experience in a single center.
Deraco M; Kusamura S; Laterza B; Favaro M; Fumagalli L; Costanzo P; Baratti D
In Vivo; 2006; 20(6A):773-6. PubMed ID: 17203766
[TBL] [Abstract][Full Text] [Related]
23. Improved Survival with Anti-VEGF Therapy in the Treatment of Unresectable Appendiceal Epithelial Neoplasms.
Choe JH; Overman MJ; Fournier KF; Royal RE; Ohinata A; Rafeeq S; Beaty K; Phillips JK; Wolff RA; Mansfield PF; Eng C
Ann Surg Oncol; 2015 Aug; 22(8):2578-84. PubMed ID: 25582740
[TBL] [Abstract][Full Text] [Related]
24. Can a Benefit be Expected from Surgical Debulking of Unresectable Pseudomyxoma Peritonei?
Delhorme JB; Elias D; Varatharajah S; Benhaim L; Dumont F; Honoré C; Goéré D
Ann Surg Oncol; 2016 May; 23(5):1618-24. PubMed ID: 26678404
[TBL] [Abstract][Full Text] [Related]
25. Intraperitoneal mitomycin C improves survival compared to cytoreductive surgery alone in an experimental model of high-grade pseudomyxoma peritonei.
Sørensen O; Andersen AM; Larsen SG; Giercksky KE; Flatmark K
Clin Exp Metastasis; 2019 Dec; 36(6):511-518. PubMed ID: 31541325
[TBL] [Abstract][Full Text] [Related]
26. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei in a liver-transplanted patient: a case report.
Thorgersen EB; Melum E; Folseraas T; Larsen SG; Line PD
World J Surg Oncol; 2018 Sep; 16(1):180. PubMed ID: 30185175
[TBL] [Abstract][Full Text] [Related]
27. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal mucinous neoplasms.
Yan TD; Links M; Xu ZY; Kam PC; Glenn D; Morris DL
Br J Surg; 2006 Oct; 93(10):1270-6. PubMed ID: 16838392
[TBL] [Abstract][Full Text] [Related]
28. Neoadjuvant chemotherapy with bevacizumab may improve outcome after cytoreduction and hyperthermic intraperitoneal chemoperfusion (HIPEC) for colorectal carcinomatosis.
Ceelen W; Van Nieuwenhove Y; Putte DV; Pattyn P
Ann Surg Oncol; 2014 Sep; 21(9):3023-8. PubMed ID: 24756812
[TBL] [Abstract][Full Text] [Related]
29. Outcome and surgical strategy in critical sites in cases of psuedomyxoma peritonei.
Mahmoud AM; Hussein MM; Moneer MM
J Egypt Natl Canc Inst; 2016 Dec; 28(4):249-255. PubMed ID: 27658904
[TBL] [Abstract][Full Text] [Related]
30. Cytoreductive surgery plus perioperative intraperitoneal chemotherapy in pseudomyxoma peritonei: aspects of the learning curve.
Andréasson H; Lorant T; Påhlman L; Graf W; Mahteme H
Eur J Surg Oncol; 2014 Aug; 40(8):930-6. PubMed ID: 24656455
[TBL] [Abstract][Full Text] [Related]
31. Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
Jimenez W; Sardi A; Nieroda C; Sittig M; Milovanov V; Nunez M; Aydin N; Gushchin V
Ann Surg Oncol; 2014 Dec; 21(13):4218-25. PubMed ID: 24986239
[TBL] [Abstract][Full Text] [Related]
32. [A single-center clinical analysis of 65 cases of pseudomyxoma peritonei from appendiceal origin in the early stage].
Ma RQ; Xia A; Zhai XC; Chen F; Xu HB
Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):698-702. PubMed ID: 31550861
[No Abstract] [Full Text] [Related]
33. Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Elias D; Honoré C; Ciuchendéa R; Billard V; Raynard B; Lo Dico R; Dromain C; Duvillard P; Goéré D
Br J Surg; 2008 Sep; 95(9):1164-71. PubMed ID: 18690633
[TBL] [Abstract][Full Text] [Related]
34. Cytoreductive surgery with intraperitoneal chemotherapy to treat pseudomyxoma peritonei at nonspecialized hospitals.
Kitai T; Kawashima M; Yamanaka K; Ichijima K; Fujii H; Mashima S; Shimahara Y
Surg Today; 2011 Sep; 41(9):1219-23. PubMed ID: 21874418
[TBL] [Abstract][Full Text] [Related]
35. Management of an inguinal hernia in patients with pseudomyxoma peritonei.
Sugarbaker PH
Eur J Surg Oncol; 2017 Jun; 43(6):1083-1087. PubMed ID: 28131668
[TBL] [Abstract][Full Text] [Related]
36. Perioperative safety after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal origin: Experience on 254 patients from a single center.
Li XB; Ma R; Ji ZH; Lin YL; Zhang J; Yang ZR; Chen LF; Yan FC; Li Y
Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):600-606. PubMed ID: 31973925
[TBL] [Abstract][Full Text] [Related]
37. Utility of Chemoresponse Assay in Patients Undergoing Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy.
Bhagwandin S; Naffouje S; Salti G
Ann Surg Oncol; 2015 Aug; 22(8):2573-7. PubMed ID: 25572680
[TBL] [Abstract][Full Text] [Related]
38. The role of baseline inflammatory-based scores and serum tumor markers to risk stratify pseudomyxoma peritonei patients treated with cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
Kusamura S; Baratti D; Hutanu I; Gavazzi C; Morelli D; Iusco DR; Grassi A; Bonomi S; Virzì S; Haeusler E; Deraco M
Eur J Surg Oncol; 2015 Aug; 41(8):1097-105. PubMed ID: 26026742
[TBL] [Abstract][Full Text] [Related]
39. CA 19-9 to peritoneal carcinomatosis index (PCI) ratio is prognostic in patients with epithelial appendiceal mucinous neoplasms and peritoneal dissemination undergoing cytoreduction surgery and intraperitoneal chemotherapy: A retrospective cohort study.
Kozman MA; Fisher OM; Rebolledo BJ; Valle SJ; Alzahrani N; Liauw W; Morris DL
Eur J Surg Oncol; 2017 Dec; 43(12):2299-2307. PubMed ID: 28993033
[TBL] [Abstract][Full Text] [Related]
40. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?
Sugarbaker PH
Lancet Oncol; 2006 Jan; 7(1):69-76. PubMed ID: 16389186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
